0000899243-23-016422.txt : 20230623
0000899243-23-016422.hdr.sgml : 20230623
20230623175220
ACCESSION NUMBER: 0000899243-23-016422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krebs Andreas
CENTRAL INDEX KEY: 0001438946
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40360
FILM NUMBER: 231038942
MAIL ADDRESS:
STREET 1: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc.
CENTRAL INDEX KEY: 0001813814
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: SUITE 8500
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: 212-220-6633
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: SUITE 8500
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-21
0
0001813814
Mind Medicine (MindMed) Inc.
MNMD
0001438946
Krebs Andreas
C/O MIND MEDICINE (MINDMED), INC
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK
NY
10007
1
0
0
0
0
Common Shares
2023-06-21
4
A
0
13671
0.00
A
15107
D
Stock Option (Right to Buy)
3.61
2023-06-21
4
A
0
19203
0.00
A
2033-06-20
Common Shares
19203
29748
D
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Common Share of the Issuer. The RSUs shall vest in four (4) equal quarterly installments from the grant date or upon the next Annual Meeting date, if earlier, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
On August 26, 2022, the Issuer effected a 1-for-15 reverse stock split (the" Reverse Stock Split"). The number of securities reported on the Form 4 have been adjusted to reflect the Reverse Stock Split.
The shares underlying the option shall vest in twelve (12) equal monthly installments starting from the grant date or upon the next Annual Meeting date, if earlier, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
/s/ Robert Barrow, Attorney-in- Fact
2023-06-23